Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,443,052
-
Share change
-
+868,329
-
Total reported value
-
$94,235,000
-
Price per share
-
$9.98
-
Number of holders
-
54
-
Value change
-
-$5,407,862
-
Number of buys
-
43
-
Number of sells
-
20
Institutional Holders of EIDOS THERAPEUTICS INC - COM (EIDX) as of Q3 2018
As of 30 Sep 2018,
EIDOS THERAPEUTICS INC - COM (EIDX) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,443,052 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, Viking Global Investors LP, Redmile Group, LLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, Foresite Capital Management IV, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Cormorant Asset Management, LP, Board of Trustees of The Leland Stanford Junior University, and AMERICAN INTERNATIONAL GROUP INC.
This page lists
54
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.